programmed death ligand protein produced tumor suppress the immune system blockers and |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : programmed deathligand pdl1 protein produced tumor suppress immune system blockers pd1 cell death surface receptor white blood apoptosis inhibitor cancer ligand nivolumab antibody melanoma metastatic pembrolizumab cd274 listeria pdb3bik structure peptide amino acid molecule polypeptide polymer atoms science scientific disease health molecular model interaction are important new anticancer drug class cartoon representation combined semitransparent surfaces |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Programmed death-ligand 1 PD-L1 protein. Produced by tumor to suppress the immune system. Blockers of the PD-L1 and PD-1 interaction are an important new anticancer drug class. Cartoon representation combined with semi-transparent surfaces |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||